Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2010
03/17/2010CN101671672A Polyanion for improved nucleic acid amplification
03/17/2010CN101671671A Element for adjusting methylation in sEH gene promoter region in human liver cancer cell
03/17/2010CN101671670A Hepatocellular carcinoma targeting gene expression element AP and applications thereof
03/17/2010CN101671669A Hepatocellular carcinoma targeting gene expression element AE and applications thereof
03/17/2010CN101671668A Hepatocellular carcinoma targeting gene expression element AG and applications thereof
03/17/2010CN101671667A Carrier for constructing hpRNA, constructing method and application thereof
03/17/2010CN101671666A Proliferation and tumor cell specific gene operating system for gene therapy of malignant tumor
03/17/2010CN101671662A Preparation method of lyase for cleaving various serotype streptococcus suis
03/17/2010CN101671653A Screening system of HIV infected cell and applications thereof
03/17/2010CN101671650A Cell type generating inducible pluripotent stem cell, preparation method and application thereof
03/17/2010CN101671646A HIV-1 integrase expression bacterial strain and integrase inhibitor in-vitro screening model
03/17/2010CN101671634A Rhamnose lactobacillus M8, rhamnose lactobacillus SLP and preparation method thereof
03/17/2010CN101671397A Anti-EGFR single-chain antibody fusion Gelonin recombination immunotoxin, preparation method and usage thereof
03/17/2010CN101671396A Vascular endothelial growth factor specifically combined with collagen and application thereof
03/17/2010CN101671393A Angiopoietin-2 specific binding agents
03/17/2010CN101671392A Monoclonal antibody resisting hemocyanin of China prawns as well as preparation method and application thereof
03/17/2010CN101671390A Human interferon alpha derivatives and preparation and use of pegylated products thereof
03/17/2010CN101671204A Green environment protective biological organic compound fertilizer and production method thereof
03/17/2010CN101670119A polynucleotide
03/17/2010CN101670105A Humanized antibodies chelated with amylord beta peptide
03/17/2010CN101670101A Attenuated live vaccine
03/17/2010CN100594239C Mutant E. coli APPA phytase enzymes
03/17/2010CN100594237C Streptococcus suis type 2 carnine acidohydrogenase deletion mycopremna
03/16/2010US7678974 Plants and seeds of corn variety CV479454
03/16/2010US7678973 Plants and seeds of corn variety CV932121
03/16/2010US7678971 Plants and seeds of hybrid corn variety CH627005
03/16/2010US7678970 Plants and seeds of hybrid corn variety CH954175
03/16/2010US7678969 Plants and seeds of hybrid corn variety CH313215
03/16/2010US7678968 Plants and seeds of hybrid corn variety CH719138
03/16/2010US7678967 Plants and seeds of corn variety CV795034
03/16/2010US7678966 Plants and seeds of corn variety CV591539
03/16/2010US7678965 Soybean variety D5624834
03/16/2010US7678964 Soybean variety D5916542
03/16/2010US7678963 Soybean variety D5896414
03/16/2010US7678962 Soybean variety 0330739
03/16/2010US7678960 Generation of plants with altered oil, protein, or fiber content
03/16/2010US7678896 Short interference RNA duplexes when introduced into mammalian cells in culture perform sequence-specific inhibition of target mRNA without inducing an interferon response; for gene silencing to treat human diseases; double stranded siRNA
03/16/2010US7678895 oligonucleotide with modified phosphorothioate linkage, sugar moiety, or nucleobase; disease or condition associated with expression of superoxide dismutase 1
03/16/2010US7678893 Fluorescent proteins from Copepoda species and methods for using same
03/16/2010US7678887 Identification and cloning of a novel human gene, RET16, involved in the intracellular signaling cascade
03/16/2010US7678885 Recombinant bone morphogenetic protein heterodimers, compositions and methods of use
03/16/2010US7678760 Inhibitors of Memapsin 2 and use thereof
03/16/2010US7678569 Cloned genome of infectious hepatitis C virus strain HC-TN and uses thereof
03/16/2010US7678564 Container with at least one electrode
03/16/2010US7678561 Robust expression of a bioactive mammalian protein in chlamydomonas chloroplast
03/16/2010US7678560 Δ 5 desaturase and its use in making polyunsaturated fatty acids
03/16/2010US7678558 Method for overexpression of zwitterionic polysaccharides
03/16/2010US7678554 Nucleic acid shuffling
03/16/2010US7678542 Charge tags and the separation of nucleic acid molecules
03/16/2010US7678376 Recombinant parainfluenza virus expression systems and vaccines
03/16/2010US7678374 Viral vectors expressing fusion of viral large envelope protein and protein of interest
03/16/2010US7678372 Tyrosine kinase inhibitors; anticancer agents; genetic engineered protein
03/16/2010US7678357 Electrical connection structure, production method thereof, and electric wiring method
03/16/2010CA2433347C Sample processing device and method
03/16/2010CA2423616C Chemokine mutants in the treatment of multiple sclerosis
03/16/2010CA2422216C Method for the production of vitamin k-dependent proteins
03/16/2010CA2345376C Water-soluble luminescent quantum dots and bioconjugates thereof
03/16/2010CA2344051C Monolithic matrix for separating nucleic acids by reverse-phase ion-pair high performance liquid chromatography
03/16/2010CA2340422C Method for producing yeast expressed hpv types 6 and 16 capsid proteins
03/16/2010CA2327311C Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins
03/16/2010CA2317118C Process for producing n-acetylneuraminic acid
03/16/2010CA2312008C Transgenic lemnaceae
03/16/2010CA2296766C Aggrecan degrading metallo proteases
03/16/2010CA2200054C Use of antibodies to block the effects of gram-positive bacteria and mycobacteria
03/12/2010CA2677398A1 Plant biochemical systems and uses thereof
03/11/2010WO2010028367A1 Gold nanorod-sirna complexes and methods of using same
03/11/2010WO2010028366A2 Methods and systems for nucleic acid sequencing validation, calibration and normalization
03/11/2010WO2010028347A2 Continuous directed evolution of proteins and nucleic acids
03/11/2010WO2010028331A1 Compositions and methods for expression of a heterologous nucleotide sequence in plants
03/11/2010WO2010028256A2 Predictive biomarkers
03/11/2010WO2010028236A1 Algorithm for designing irreversible inhibitors
03/11/2010WO2010028110A2 Sequence variations in pnpla3 associated with hepatic steatosis
03/11/2010WO2010028054A1 Compositions and methods for inhibiting expression of mutant egfr gene
03/11/2010WO2010028019A2 Direct reprogramming of somatic cells using non-integrating vectors
03/11/2010WO2010027981A1 Multispecific antibodies
03/11/2010WO2010027977A2 Colorimetric bioassay for perchlorate
03/11/2010WO2010027948A2 Methods and compositions for increased alpha-prime beta-conglycinin soybeans
03/11/2010WO2010027870A2 Assay methods for increased throughput of samples and/or targets
03/11/2010WO2010027838A1 Mir 204, mir 211, their anti-mirs, and therapeutic uses of same
03/11/2010WO2010027832A1 Method for reducing scarring during wound healing using antisense compounds directed to ctgf
03/11/2010WO2010027799A1 Modified bacillus thuringiensis cry5 proteins for nematode control
03/11/2010WO2010027793A1 Nematode-resistant plants, and modified bacillus thuringiensis cry genes and proteins
03/11/2010WO2010027729A2 Gonococcal vaccines
03/11/2010WO2010027710A2 Ketoreductase polypeptides and uses thereof
03/11/2010WO2010027531A1 Engineered light-emitting reporter genes and medthods of use
03/11/2010WO2010027516A2 Transgenically preventing establishment and spread of transgenic algae in natural ecosystems
03/11/2010WO2010027506A2 Genetically engineered herbicide resistance for maintaining axenic cultures
03/11/2010WO2010027505A2 Decreasing rubisco content of algae and cyanobacteria cultivated in high carbon dioxide
03/11/2010WO2010027497A2 Preparations, compositions, and methods for nucleic acid sequencing
03/11/2010WO2010027484A2 Engineering polymerases and reaction conditions for modified incorporation properties
03/11/2010WO2010027326A1 Peptide nucleic acid monomers and oligomers
03/11/2010WO2010027279A2 Compositions and methods for the treatment and prevention of neoplastic disorders
03/11/2010WO2010027233A2 Novel hydrogenase isolated from thermococcus sp., gene encoding the same, and method for producing hydrogen using microorganisms with the gene
03/11/2010WO2010027094A1 NKT CELL-DERIVED iPS CELLS AND NKT CELLS DERIVED THEREFROM
03/11/2010WO2010027062A1 B cell-derived ips cells and application thereof
03/11/2010WO2010027045A1 Microorganism capable of producing l-amino acid, and method for producing l-amino acid
03/11/2010WO2010027022A1 Bacterium capable of producing l-amino acid, and method for producing l-amino acid
03/11/2010WO2010026965A1 Cell capable of replicating novel hcv replicon, cell capable of replicating full-length hcv rna, and use of those cells
03/11/2010WO2010026950A1 Dna detection apparatus, dna detection device and dna detection method
03/11/2010WO2010026933A1 Composition for detection of rna